ROHTO PHARMACEUTICAL CO.,LTD. (4527) Dividends
Market cap
¥581.2B
P/E ratio
16.9x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
Latest Dividend per Share Forecast
44.00JPY
If you buy 100 shares of ROHTO PHARMACEUTICAL CO.,LTD., the expected annual dividend is 4,400 JPY.
- Dividend Yield
- 1.8%
- Payout Ratio
- 30.5%
Dividend Policy
<p>We prioritize stable and continuous returns to shareholders as a key management objective, with dividends determined based on business performance. We pay dividends twice annually—an interim dividend and a year-end dividend. We reinvest retained earnings in product development, manufacturing equipment, and new business initiatives to support future stable and higher-level dividends.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Revision(2026/02/12) | 21 | 23 | 44 | - |
|---|---|---|---|---|---|
| Revision(2025/11/13) | 21 | 22 | 43 | - | |
| Forecast(2025/05/13) | 21 | 21 | 42 | 30.5% | |
| FY2025 | Actual(2025/05/13) | 16 | 20 | 36 | 26.4% |
| Revision(2025/02/12) | 16 | 20 | 36 | - | |
| Revision(2024/08/07) | 16 | 17 | 33 | - | |
| Forecast(2024/05/13) | 15 | 15 | 30 | 21.4% | |
| FY2024 | Actual(2024/05/13) | 12 | 15 | 27 | 19.9% |
| Revision(2023/11/10) | 12 | 15 | 27 | - | |
| Forecast(2023/05/12) | 12 | 12 | 24 | 20.7% | |
| FY2023 | Actual(2023/05/12) | 20 | 12 | - | 19.0% |
| Revision(2023/02/13) | 20 | 12 | 32 | - | |
| Revision(2022/11/10) | 20 | 10 | - | - | |
| Revision(2022/08/09) | 20 | 20 | 40 | - | |
| Forecast(2022/05/12) | 18 | 19 | 37 | 21.6% | |
| FY2022 | Actual(2022/05/12) | 15 | 21 | 36 | 19.5% |
| Revision(2022/02/10) | 15 | 21 | 36 | - | |
| Forecast(2021/05/12) | 15 | 15 | 30 | 20.0% | |
| FY2021 | Actual(2021/05/12) | 13 | 15 | 28 | 19.1% |
| Forecast(2020/11/12) | 13 | 14 | 27 | - | |
| FY2020 | Actual(2020/11/12) | 13 | 13 | 26 | - |